SelectQuote, Inc. (NYSE:SLQT – Get Free Report) passed below its 50-day moving average during trading on Monday. The stock has a 50-day moving average of $0.41 and traded as low as $0.3640. SelectQuote shares last traded at $0.3760, with a volume of 1,638,686 shares.
Wall Street Analyst Weigh In
Several research firms have weighed in on SLQT. Zacks Research upgraded SelectQuote from a “strong sell” rating to a “hold” rating in a research note on Monday, October 26th. Weiss Ratings reissued a “sell (d)” rating on shares of SelectQuote in a report on Friday. Finally, Wall Street Zen raised shares of SelectQuote to a “hold” rating in a report on Saturday. One analyst has rated the stock with a Strong Buy rating, two have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $3.00.
Read Our Latest Analysis on SLQT
SelectQuote Stock Performance
The business’s fifty day moving average price is $0.41 and its two-hundred day moving average price is $0.72. The company has a debt-to-equity ratio of 1.16, a quick ratio of 7.48 and a current ratio of 7.48. The stock has a market capitalization of $67.47 million, a P/E ratio of -12.53 and a beta of 2.01.
SelectQuote (NYSE:SLQT – Get Free Report) last announced its earnings results on Wednesday, November 4th. The company reported ($0.21) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.33) by $0.12. SelectQuote had a net margin of 4.61% and a return on equity of 22.48%. The firm had revenue of $280.01 million for the quarter, compared to analysts’ expectations of $277.91 million. As a group, sell-side analysts forecast that SelectQuote, Inc. will post -0.25 earnings per share for the current year.
Insiders Place Their Bets
In other news, Director Donald Hawks, III acquired 223,402 shares of the company’s stock in a transaction on Monday, November 9th. The stock was bought at an average cost of $0.46 per share, with a total value of $102,764.92. Following the completion of the purchase, the director directly owned 763,214 shares of the company’s stock, valued at $351,078.44. This represents a 41.39% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, COO William Grant, III acquired 79,600 shares of the business’s stock in a transaction on Friday, November 6th. The shares were purchased at an average price of $0.51 per share, for a total transaction of $40,596.00. Following the transaction, the chief operating officer directly owned 3,468,094 shares of the company’s stock, valued at approximately $1,768,727.94. The trade was a 2.35% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Over the last three months, insiders purchased 919,905 shares of company stock worth $446,916. 11.60% of the stock is currently owned by company insiders.
Institutional Trading of SelectQuote
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. BlackRock Inc. bought a new stake in SelectQuote in the second quarter worth about $1,836,000. GSA Capital Partners LLP purchased a new stake in shares of SelectQuote in the second quarter worth approximately $1,123,000. Renaissance Technologies LLC raised its holdings in shares of SelectQuote by 817.6% in the first quarter. Renaissance Technologies LLC now owns 1,021,239 shares of the company’s stock worth $643,000 after buying an additional 909,939 shares during the period. Squarepoint Ops LLC purchased a new stake in shares of SelectQuote in the second quarter worth approximately $536,000. Finally, Connor Clark & Lunn Investment Management Ltd. bought a new stake in shares of SelectQuote during the 2nd quarter worth approximately $461,000. 34.59% of the stock is owned by hedge funds and other institutional investors.
About SelectQuote
SelectQuote, Inc. operates a direct-to-consumer insurance distribution platform that helps consumers compare coverage from multiple insurance providers. Its licensed agents assist customers with evaluating options and selecting policies. The company offers Medicare-related products, including Medicare Advantage, Medicare Supplement and prescription drug plans, as well as life, auto and home insurance. Its services also include SelectRx, which provides pharmacy and medication-management services.
Further Reading
- Five stocks we like better than SelectQuote
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
Receive News & Ratings for SelectQuote Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SelectQuote and related companies with MarketBeat.com's FREE daily email newsletter.
